DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

IVIM Health vs LillyDirect (Zepbound): November 2026 prices compared

As of November 20, 2026, neither IVIM Health nor LillyDirect (Zepbound) printed a month-to-month compounded price that applies at the maintenance dose, so this page compares what each did show and how each bills, without a price verdict.

Released · Last reviewed · how we verify

IVIM Health and LillyDirect (Zepbound), measure by measure

IVIM Health and LillyDirect (Zepbound) side by side, from each program’s own page read November 20, 2026 (all-in: medication plus any required recurring fee, before tax)
MeasureIVIM HealthLillyDirect (Zepbound)
Tirzepatide, month to monthfrom $192 (per month, starting-dose price)—
Tirzepatide, lowest printed$192 ($117 + $75 program fee)—
Semaglutide, month to monthfrom $140 (per month, starting-dose price)—
Semaglutide, lowest printed$140 ($65 + $75 program fee)—
Dose pricingpriced by dose or not statedpriced by dose or not stated
Membership or program feeabout $75 a monthnone
Computed score8 of 40 (position 18 of 27)not scored (brand route)
FDA warning letters721816 (2026-02-20)none listed
November 20 readfirst-party readfirst-party read

Strengths and limitations: which fits whom

IVIM Health prices by dose, so its printed figure covers the first months; budget for a higher maintenance-dose price. LillyDirect (Zepbound) suits someone who wants brand medication, FDA-approved, and accepts a higher monthly cost or has coverage. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.

What changed since August

The first version of this comparison used captures from August 5–10, 2026. The November 20 re-read replaces them; the August figures are kept below as history, dated.

What changed since the August 2026 capture (maintenance-dose all-in figure then; month-to-month all-in figure read November 20, 2026)
ProgramMedicationAugust 5–10, 2026November 20, 2026
IVIM Healthtirzepatide—from $192
IVIM Healthsemaglutide—from $140

Regulatory record

FDA’s warning-letter index lists warning letter 721816 (dated February 20, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to IVIM Health; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Check IVIM Health’s current prices ↗
Check LillyDirect (Zepbound)’s current prices ↗

Frequently asked

Which is cheaper, IVIM Health or LillyDirect (Zepbound)?

Neither printed a comparable month-to-month price on November 20, 2026, so there is no like-for-like answer this month.

Do IVIM Health and LillyDirect (Zepbound) charge a membership fee?

IVIM Health: about $75 a month on top of medication; LillyDirect (Zepbound): no membership fee. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.

Are IVIM Health and LillyDirect (Zepbound) medications FDA-approved?

Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.

IVIM Health recordIVIM Health alternativesLillyDirect (Zepbound) recordAll head-to-headsRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.